Crossref journal-article
Ovid Technologies (Wolters Kluwer Health)
Melanoma Research (276)
Bibliography

Bloethner, S., Hemminki, K., Thirumaran, R. K., Chen, B., Mueller-Berghaus, J., Ugurel, S., Schadendorf, D., & Kumar, R. (2006). Differences in global gene expression in melanoma cell lines with and without homozygous deletion of the CDKN2A locus genes. Melanoma Research, 16(4), 297–307.

Authors 8
  1. Sandra Bloethner (first)
  2. Kari Hemminki (additional)
  3. Ranjit K. Thirumaran (additional)
  4. Bowang Chen (additional)
  5. Jan Mueller-Berghaus (additional)
  6. Selma Ugurel (additional)
  7. Dirk Schadendorf (additional)
  8. Rajiv Kumar (additional)
References 46 Referenced 15
  1. 10.1046/j.1523-1747.2002.00217.x / J Invest Dermatol / Pathways to melanoma development: lessons from the mouse by Walker (2002)
  2. 10.1038/sj.onc.1206461 / Oncogene / The INK4a/ARF locus and melanoma by Sharpless (2003)
  3. 10.1136/jmg.2004.019349 / J Med Genet / Prospective risk of cancer in CDKN2A germline mutation carriers by Goldstein (2004)
  4. 10.1038/sj.onc.1206445 / Oncogene / Genetics of melanoma predisposition by Hayward (2003)
  5. 10.1002/cncr.11562 / Cancer / Characterization of the neoplastic phenotype in the familial atypical multiple-mole melanoma-pancreatic carcinoma syndrome by Rulyak (2003)
  6. 10.1001/archderm.139.8.1019 / Arch Dermatol / Pancreatic carcinoma surveillance in patients with familial melanoma by Parker (2003)
  7. {'key': 'R7-4-20210129', 'first-page': 'F115', 'article-title': 'The p16INK4a/CDKN2A tumor suppressor and its relatives', 'volume': '1378', 'author': 'Ruas', 'year': '1998', 'journal-title': 'Biochim Biophys Acta'} / Biochim Biophys Acta / The p16INK4a/CDKN2A tumor suppressor and its relatives by Ruas (1998)
  8. 10.1038/nature00766 / Nature / Mutations of the BRAF gene in human cancer by Davies (2002)
  9. {'key': 'R9-4-20210129', 'first-page': '3362', 'article-title': 'BRAF mutations in metastatic melanoma: a possible association with clinical outcome', 'volume': '9', 'author': 'Kumar', 'year': '2003', 'journal-title': 'Clin Cancer Res'} / Clin Cancer Res / BRAF mutations in metastatic melanoma: a possible association with clinical outcome by Kumar (2003)
  10. 10.1038/sj.onc.1206909 / Oncogene / Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9 by Kumar (2003)
  11. {'key': 'R11-4-20210129', 'first-page': '756', 'article-title': 'Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation', 'volume': '63', 'author': 'Satyamoorthy', 'year': '2003', 'journal-title': 'Cancer Res'} / Cancer Res / Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation by Satyamoorthy (2003)
  12. 10.1016/j.cub.2005.01.031 / Curr Biol / BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma by Patton (2005)
  13. 10.1038/35092584 / Nature / Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice by Krimpenfort (2001)
  14. 10.1038/35092592 / Nature / Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis by Sharpless (2001)
  15. 10.1038/sj.onc.1207074 / Oncogene / The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis by Sharpless (2004)
  16. 10.1172/JCI22475 / J Clin Invest / Ink4a/Arf expression is a biomarker of aging by Krishnamurthy (2004)
  17. 10.4161/cc.3.5.859 / Cell Cycle / Unraveling human tumor suppressor pathways: a tale of the INK4A locus by Voorhoeve (2004)
  18. 10.1093/jnci/94.6.446 / J Natl Cancer Inst / p16(Ink4a) in melanocyte senescence and differentiation by Sviderskaya (2002)
  19. {'key': 'R19-4-20210129', 'first-page': '723', 'article-title': 'p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: possible implications for melanoma progression', 'volume': '95', 'author': 'Sviderskaya', 'year': '2003', 'journal-title': 'JNCI Cancer Spectrum'} / JNCI Cancer Spectrum / p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: possible implications for melanoma progression by Sviderskaya (2003)
  20. 10.1111/j.0022-202X.2004.23312.x / J Invest Dermatol / Longitudinal assessment of the nevus phenotype in a melanoma kindred by Florell (2004)
  21. 10.1038/35059131 / Nature / Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence by Ohtani (2001)
  22. 10.1038/nature02958 / Nature / p19ARF directly and differentially controls the functions of c-Myc independently of p53 by Qi (2004)
  23. 10.1158/0008-5472.CAN-03-2519 / Cancer Res / The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements by D'Amico (2004)
  24. {'key': 'R24-4-20210129', 'first-page': '388', 'article-title': 'A single nucleotide polymorphism in the 3′ untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare', 'volume': '95', 'author': 'Kumar', 'year': '2001', 'journal-title': 'Int J Cancer'} / Int J Cancer / A single nucleotide polymorphism in the 3′ untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare by Kumar (2001)
  25. 10.1002/(SICI)1097-0215(19980119)75:2<193::AID-IJC5>3.0.CO;2-P / Int J Cancer / Mutations in the CDKN2A (p16INK4a) gene in microdissected sporadic primary melanomas by Kumar (1998)
  26. {'key': 'R26-4-20210129', 'first-page': '235', 'article-title': 'Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR', 'volume': '9', 'author': 'Berggren', 'year': '2003', 'journal-title': 'Clin Cancer Res'} / Clin Cancer Res / Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR by Berggren (2003)
  27. 10.1093/carcin/bgi066 / Carcinogenesis / Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines by Bloethner (2005)
  28. 10.1073/pnas.091062498 / Proc Natl Acad Sci USA / Significance analysis of microarrays applied to the ionizing radiation response by Tusher (2001)
  29. 10.1073/pnas.96.6.2907 / Proc Natl Acad Sci USA / Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation by Tamayo (1999)
  30. 10.1038/sj.onc.1205558 / Oncogene / Multiple interacting domains contribute to p14ARF mediated inhibition of MDM2 by Clark (2002)
  31. 10.1002/(SICI)1098-2264(199811)23:3<273::AID-GCC11>3.0.CO;2-N / Genes Chromosomes Cancer / Selective deletion of exon 1b of the p19ARF gene in metastatic melanoma cell lines by Kumar (1998)
  32. 10.1093/hmg/10.1.55 / Hum Mol Genet / A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family by Randerson-Moor (2001)
  33. 10.1038/nature03269 / Nature / Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression by Carreira (2005)
  34. 10.1034/j.1600-0749.2002.00056.x / Pigment Cell Res / Comparative biochemistry of eumelanogenesis and the protective roles of phenoloxidase and melanin in insects by Sugumaran (2002)
  35. 10.1111/j.1349-7006.2004.tb03320.x / Cancer Sci / ETS transcription factors: possible targets for cancer therapy by Oikawa (2004)
  36. 10.1111/j.1349-7006.2004.tb03184.x / Cancer Sci / Promoter methylation profiling of 30 genes in human malignant melanoma by Furuta (2004)
  37. 10.1002/jcp.10215 / J Cell Physiol / Cancer/testis-associated genes: identification, expression profile, and putative function by Zendman (2003)
  38. 10.1158/1078-0432.CCR-05-1544 / Clin Cancer Res / Tumor antigen expression in melanoma varies according to antigen and stage by Barrow (2006)
  39. 10.1034/j.1600-0625.2002.110402.x / Exp Dermatol / mRNA expression of tumor-associated antigens in melanoma tissues and cell lines by Eichmuller (2002)
  40. 10.1016/S0002-9440(10)64315-5 / Am J Pathol / Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer by Furukawa (2003)
  41. 10.1038/ncb867 / Nat Cell Biol / Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway by Hanafusa (2002)
  42. 10.1093/emboj/19.24.6778 / EMBO J / TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins by Kanai (2000)
  43. 10.1158/0008-5472.CAN-04-1399 / Cancer Res / Deregulated Akt3 activity promotes development of malignant melanoma by Stahl (2004)
  44. 10.1158/0008-5472.CAN-04-2095 / Cancer Res / Id2 drives differentiation and suppresses tumor formation in the intestinal epithelium by Russell (2004)
  45. 10.1023/B:HIJO.0000032357.16261.c5 / J Mol Histol / Tumour biological aspects of CD24, a mucin-like adhesion molecule by Kristiansen (2004)
  46. 10.1046/j.1523-1747.2002.01866.x / J Invest Dermatol / Gene transfer of secreted-type modified interleukin-18 gene to B16F10 melanoma cells suppresses in vivo tumor growth through inhibition of tumor vessel formation by Nagai (2002)
Dates
Type When
Created 19 years, 1 month ago (July 14, 2006, 8:42 a.m.)
Deposited 4 years, 4 months ago (April 10, 2021, 12:21 a.m.)
Indexed 1 year, 9 months ago (Nov. 15, 2023, 7:44 a.m.)
Issued 19 years, 1 month ago (Aug. 1, 2006)
Published 19 years, 1 month ago (Aug. 1, 2006)
Published Print 19 years, 1 month ago (Aug. 1, 2006)
Funders 0

None

@article{Bloethner_2006, title={Differences in global gene expression in melanoma cell lines with and without homozygous deletion of the CDKN2A locus genes}, volume={16}, ISSN={0960-8931}, url={http://dx.doi.org/10.1097/01.cmr.0000222597.50309.05}, DOI={10.1097/01.cmr.0000222597.50309.05}, number={4}, journal={Melanoma Research}, publisher={Ovid Technologies (Wolters Kluwer Health)}, author={Bloethner, Sandra and Hemminki, Kari and Thirumaran, Ranjit K. and Chen, Bowang and Mueller-Berghaus, Jan and Ugurel, Selma and Schadendorf, Dirk and Kumar, Rajiv}, year={2006}, month=aug, pages={297–307} }